HOME >> BIOLOGY >> NEWS
University of Pittsburgh findings published in Science illustrate how KSHV causes cancer

PITTSBURGH, Nov. 14 Findings published in this week's issue of the journal Science by researchers at the University of Pittsburgh Cancer Institute (UPCI) illustrate how the virus that causes Kaposi's sarcoma Kaposi's sarcoma-associated herpesvirus, or KSHV inhibits the body's immune response and causes cancer cells to grow through a technique called immune evasion. KSHV causes Kaposi's sarcoma, a cancer of the blood vessel cells that often occurs in tissues under the skin or mucous membranes, and is the most common malignancy occurring among AIDS patients. KSHV belongs to the family of herpesviruses that includes the causes of genital herpes, cold sores and chickenpox.

Patrick S. Moore, M.D., M.P.H., professor, department of molecular genetics and biochemistry, and Yuan Chang, M.D., professor, department of pathology the team who previously discovered KSHV examined the expression of a virus-derived cytokine (a hormone-like substance that regulates cells during an immune response) in KSHV. Dr. Moore and Dr. Chang found that this cytokine, viral IL-6 (vIL-6), not only inhibits immune function, but also causes cancerous cells to grow. vIL-6 protects virus-infected cells from undergoing growth arrest and apoptosis, or cell death, which is the normal way that the immune system attempts to limit viral infections.

"The importance of this finding is that it demonstrates that there is an overlap between the immune system and tumor suppressor pathways which are targeted by KSHV," said Dr. Moore, also director of the molecular virology program at UPCI. "It further demonstrates that viruses which inhibit immune functions also can, under some circumstances, induce tumor cells to grow because these viruses are attacking pathways that are important in both immunity and suppression of tumor growth."

Through a series of assays, the investigators examined how vIL-6 inhibits the signaling of antiviral factor interferon, or IFN. The signaling of IFN
'"/>

Contact: Clare Collins
412-624-2607
University of Pittsburgh Medical Center
14-Nov-2002


Page: 1 2

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/23/2020)... ... April 23, 2020 , ... Despite the current COVID-19 ... infrastructure products for the animal feed, human consumption, wastewater, and biotech sectors, and ... supply channels from overseas competitors have become weakened or shut down completely, new ...
(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... Worcester Polytechnic ... to help provide critical medical supplies to address the expected spike of COVID-19 cases. ... ) initiative, WPI has arranged for 3D printers and other materials to be sent ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 04, 2020 , ... Red ... life sciences industry, today announced that Informa Training Partners, a life sciences training ... to Red Nucleus Boston, effective immediately. , “The name change solidifies a stronger ...
(Date:5/1/2020)... ... April 30, 2020 , ... The winners ... businesses, policies, projects, and concepts that are actively engaged and deeply committed to ... which has taken out the top prize in the Experimental category. , The ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics company ... Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO Dr. ... 2014 before stepping into the CEO role in 2017. , In concert ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Research (SBIR) program to support the expansion of its digital health platform enabling ... conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government awards ...
Breaking Biology Technology:
Cached News: